Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Kitamura

Showing results (11-20 of 498) with videos related to

Pageof 50
Sort By:
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|February 23, 2005
Impairment of change in diameter of the hepatic portion of the inferior vena cava: a sonographic sign of liver fibrosis or cirrhosisHiroshi Kitamura, Chujiro Kobayashi
International Journal of Clinical Oncology|March 2, 2006
Early bladder cancer: concept, diagnosis, and managementHiroshi Kitamura, Taiji Tsukamoto
Cancers|November 12, 2013
Immunotherapy for urothelial carcinoma: current status and perspectivesHiroshi Kitamura, Taiji Tsukamoto
Cancer Science|February 17, 2018
NRF2 addiction in cancer cellsHiroshi Kitamura, Hozumi Motohashi
International Journal of Urology : Official Journal of the Japanese Urological Association|July 12, 2017
Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approachesDong Fang, Hiroshi Kitamura
Current Opinion in Urology|September 9, 2025
Oncolytic virus therapy for nonmuscle-invasive bladder cancer: current status and future directionsHiroshi Kitamura, Naotaka Nishiyama
European Urology|March 21, 2026
Reply to Roberto Contieri, Massimo Lazzeri, Sisto Perdonà, and Rodolfo Hurle's Letter to the Editor re: Kitamura, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008Hiroshi Kitamura, Hiroyuki Nishiyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2004
[Hemodialysis for chronic renal failure in the elderly]Hiroshi Kitamura, Masamitsu Fujii
Japanese Journal of Clinical Oncology|January 14, 2015
Treatment and management of high-grade T1 bladder cancer: what should we do after second TUR?Hiroshi Kitamura, Yoshiyuki Kakehi
Indian Journal of Urology : IJU : Journal of the Urological Society of India|May 27, 2009
Prognostic biomarkers of renal cell carcinoma: Recent advancesHiroshi Kitamura, Taiji Tsukamoto
Pageof 50

Showing results (11-20 of 498) with videos related to

Sort By:
Pageof 50
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|February 23, 2005
Impairment of change in diameter of the hepatic portion of the inferior vena cava: a sonographic sign of liver fibrosis or cirrhosisHiroshi Kitamura, Chujiro Kobayashi
International Journal of Clinical Oncology|March 2, 2006
Early bladder cancer: concept, diagnosis, and managementHiroshi Kitamura, Taiji Tsukamoto
Cancers|November 12, 2013
Immunotherapy for urothelial carcinoma: current status and perspectivesHiroshi Kitamura, Taiji Tsukamoto
Cancer Science|February 17, 2018
NRF2 addiction in cancer cellsHiroshi Kitamura, Hozumi Motohashi
International Journal of Urology : Official Journal of the Japanese Urological Association|July 12, 2017
Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approachesDong Fang, Hiroshi Kitamura
Current Opinion in Urology|September 9, 2025
Oncolytic virus therapy for nonmuscle-invasive bladder cancer: current status and future directionsHiroshi Kitamura, Naotaka Nishiyama
European Urology|March 21, 2026
Reply to Roberto Contieri, Massimo Lazzeri, Sisto Perdonà, and Rodolfo Hurle's Letter to the Editor re: Kitamura, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008Hiroshi Kitamura, Hiroyuki Nishiyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2004
[Hemodialysis for chronic renal failure in the elderly]Hiroshi Kitamura, Masamitsu Fujii
Japanese Journal of Clinical Oncology|January 14, 2015
Treatment and management of high-grade T1 bladder cancer: what should we do after second TUR?Hiroshi Kitamura, Yoshiyuki Kakehi
Indian Journal of Urology : IJU : Journal of the Urological Society of India|May 27, 2009
Prognostic biomarkers of renal cell carcinoma: Recent advancesHiroshi Kitamura, Taiji Tsukamoto
Pageof 50